Guru Ownership Trend
Guru Analysis for Soleno Therapeutics, Inc. (SLNO)
Soleno Therapeutics, Inc. (SLNO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $9.05 M.
Top institutional holders include Chuck Royce and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $6.66 M net inflow during the quarter.
Recent activity highlights Chuck Royce who increased their stake by 316.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Soleno Therapeutics, Inc. (SLNO)
Major holders include Chuck Royce ($5.97 M), Cliff Asness ($2.72 M), Jefferies Group ($1.36 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 229,229 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $6.66 M, with 4 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in SLNO during the most recent reporting period.
Yes, 1 managers opened new positions in SLNO, and 3 increased their existing holdings. The total reported buy value was $6.66 M.